Particulars Number Cytogenetic Response (Peripheral Blood)  Complete   Partial      No response   Gender Male 16 14 01 01 Female 14 11 01 02 Age >45 11 10 00 01 <45 19 15 02 02 Dwelling Urban 12 09 01 02 Rural 18 16 01 01 TLC+Spleen (Baseline) Raised 30 ------ ------ ------ Normal 30 ------ ------ ------ BCR-ABL q-PCR value (Baseline) >80% 30 ------ ------ ------ <80% 00 ------ ------ ------  Karyotyping (Baseline) Ph+ve(>80%) 30 ------ ------ ------ Ph-ve 00 ------ ------ ------ TLC+Spleen (Follow up) Raised 03      00 00 03 Normal 27 25 02 00 BCR-ABL q-PCR value (Follow-up) 0-40 % 25 ------ ------ 40-60% ------ 02 ------ 60-80% ------ ------ 03 Karyotyping (Follow up) Ph+ve 03 00 00 03 Ph-ve 27 25 02 00

Table 2: Patients particulars and ‘Peripheral blood cytogenetic response’ at 6 months of ‘Imatinib’ treatment.